| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| CEBPA |
bone marrow-derived mesenchymal stem cells |
adipose media day 7 |
Permissive
Robust
|
Mus musculus |
GSE79813
...
|
MA0019.1
...
|
| CEBPA |
bone marrow-derived macrophages |
cells differentiated in the presence of MCSF |
Permissive
Robust
|
Mus musculus |
GSE106705
...
|
MA0019.1
...
|
| CEBPA |
bone marrow-derived macrophages |
cells differentiated in the presence of MCSF (1h IL4) |
Permissive
Robust
|
Mus musculus |
GSE106705
...
|
MA0019.1
...
|
| CEBPA |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: ethanol; Genotype: Kkasumi1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: estradiol; Genotype: Kkasumi1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
HMM (HOXA9 transormed myeloblasts) |
Genotype: HOXA9/MEIS1-transformed Treament: culture conditions Myeloid (10ng/mL IL3) + 100nM 4OHT for 25 -31 days Source: in- bone marrow |
Permissive
Robust
|
Mus musculus |
GSE103446
...
|
MA0019.1
...
|
Showing 10 records in page 66
from 772 pages